Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
+31,031 sh · $306.6K
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
+31,031 sh · $306.6K
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
+37,945 sh · $374.9K
Doyle Mittie
Avalo Therapeutics Inc · NASDAQ
−1,000 sh · $20.0K
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
−31,031 sh · $622.3K
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
−3,749 sh · $74.8K
Doyle Mittie
Avalo Therapeutics Inc · NASDAQ
+1,000 sh · $12.7K
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
−37,945 sh · $753.3K
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
+2,876 sh · $28.4K
Renaissance Technologies
Avalo Therapeutics Inc · NASDAQ
120,114 sh · $1.8M
Two Sigma Investments
Avalo Therapeutics Inc · NASDAQ
64,425 sh · $961.9K